Lurz, Martin
Gemesi, Kathrin
Holzmann, Sophie Laura
Kretzschmar, Birgit
Wintergerst, Monika
Groh, Georg
Böhm, Markus
Gedrich, Kurt
Hauner, Hans
Krcmar, Helmut
Holzapfel, Christina
Funding for this research was provided by:
Technische Universität München
Article History
Received: 7 August 2023
Accepted: 18 March 2024
First Online: 4 April 2024
Declarations
:
: Approval for this survey was given by the Ethical Committee of the School of Medicine & Health at the Technical University of Munich (729/20 S). Furthermore, it was registered in the German Clinical Trials Register (DRKS00023984). Giving informed consent as well as acceptance of the privacy statement was required for participation. Informed consent was obtained from all the participants in the study.
: Not applicable.
: ML, KaG, SLH, BK, MW, GG, KuG, MB, and HK declare that they have no competing interests. HH is a member of the scientific advisory board of Oviva AG (Zurich, Switzerland). CH is a member of the scientific advisory board of 4sigma GmbH (Oberhaching, Germany).